Whether methotrexate administration in graft-versus-host disease prophylaxis significantly delays the engraftment in allogeneic peripheral blood progenitor cell transplantation

MeSH terms

• Acute Disease
• Adolescent
• Adrenal Cortex Hormones / therapeutic use
• Adult
• Bone Marrow Transplantation / adverse effects
• Cyclosporine / therapeutic use
• Graft Survival / drug effects*
• Graft vs Host Disease / drug therapy
• Graft vs Host Disease / prevention & control*
• Hematopoietic Stem Cell Transplantation* / adverse effects
• Humans
• Leukemia / therapy
• Male
• Methotrexate / administration & dosage
• Methotrexate / adverse effects*
• Methotrexate / therapeutic use
• Middle Aged